I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Ocular Ischemic Syndrome: What Patients Need to Know
What Is Ocular Ischemic Syndrome
OIS develops when the eye is chronically deprived of adequate blood flow. Understanding the anatomy involved helps explain why this condition affects the eye so severely and why its consequences extend beyond vision alone.
The internal carotid artery on each side of the neck supplies blood to the brain, the face, and the eye. The ophthalmic artery, which feeds the eye directly, is the first major branch of the internal carotid artery. When the carotid artery becomes severely narrowed due to atherosclerosis (the buildup of fatty deposits inside artery walls), the ophthalmic artery receives significantly less blood. The result is that the eye does not receive enough oxygen or nutrients to function properly.
Blood flow to the eye remains relatively stable until the carotid artery is narrowed by more than half. As narrowing becomes more severe, the blood pressure inside the central retinal artery (the artery that travels through the optic nerve and branches across the back of the eye) can drop dramatically. This sharp drop in pressure is what triggers the signs and symptoms of OIS.
The retina is the thin, light-sensitive tissue lining the back of the eye. It converts light into electrical signals that travel through the optic nerve to the brain, producing the images we see. The retina has one of the highest metabolic demands of any tissue in the human body, meaning it requires a constant and generous supply of oxygen and nutrients to function.
When retinal blood flow is reduced, the retina becomes ischemic, a term meaning it is being starved of oxygen. Prolonged ischemia can damage or destroy retinal cells, stimulate the growth of abnormal new blood vessels, and lead to irreversible vision loss. The longer the retina goes without adequate blood flow, the greater the risk of permanent damage.
Not all patients with severe carotid artery disease develop OIS. The body has backup blood pathways called collateral circulation, which can reroute blood to the eye when the primary pathway is compromised. Patients with well-developed connections between the internal and external carotid arteries may avoid OIS even if one internal carotid artery is completely blocked.
In contrast, patients with poor collateral circulation may develop OIS from a relatively modest degree of narrowing. This is why OIS does not affect every patient with carotid artery disease equally, and why some individuals present with advanced eye findings while others with similar artery disease have none.
Who Is at Risk for Ocular Ischemic Syndrome
Certain groups of patients face a meaningfully higher risk of developing OIS. Recognizing these risk factors is important for early identification and intervention before serious damage occurs.
OIS most commonly affects adults between the ages of 50 and 80, with the average age at diagnosis around 65. Men develop OIS approximately twice as often as women, a pattern that reflects the higher prevalence of cardiovascular disease in men. Anyone in this age range who has known vascular risk factors should discuss eye health monitoring with their care team.
OIS is closely associated with conditions that promote atherosclerosis throughout the body. Research has found the following conditions to be significantly more common in patients with OIS than in the general population:
- High blood pressure (hypertension), present in more than half of OIS patients
- Diabetes mellitus, also present in more than half of OIS patients
- Peripheral vascular disease (narrowing of arteries in the legs and elsewhere in the body)
- Coronary artery disease and prior heart attack
- Previous stroke or transient ischemic attack (a brief interruption of blood flow to the brain, sometimes called a mini-stroke)
- A history of kidney failure treated with dialysis
Having one or more of these conditions does not guarantee that OIS will develop, but it does underscore the importance of regular eye exams and prompt attention to any new changes in vision.
OIS is uncommon, with an estimated occurrence of approximately 7.5 cases per million people each year. Despite its rarity, the consequences are serious. Research suggests that roughly 5 percent of patients with significant carotid artery narrowing or complete blockage develop detectable eye signs of OIS. Given how widespread carotid artery disease is among older adults with cardiovascular risk factors, prompt evaluation remains essential whenever OIS is suspected.
Signs and Symptoms of Ocular Ischemic Syndrome
OIS produces a range of symptoms that reflect the degree of blood flow reduction in the eye. Some patients notice dramatic changes, while others have no symptoms at all when the condition is first discovered during a routine examination.
Vision loss is the most common symptom of OIS, affecting the large majority of patients at the time of diagnosis. The vision loss typically develops gradually over days to weeks rather than occurring all at once. In some patients, the decline is slow enough to go unnoticed until a dilated eye examination reveals significant retinal changes. In others, the change is more noticeable, and they seek care promptly. A smaller number of patients have no visual symptoms at all when OIS is first detected.
A dull, aching pain around the affected eye and eyebrow is a distinctive symptom of OIS. This discomfort is sometimes called ocular angina because it is caused by insufficient blood flow to the eye and surrounding tissues, similar in concept to the chest pain that occurs when the heart muscle does not receive enough blood. The pain may be mild and easily overlooked, or it may be persistent and bothersome enough to prompt a medical visit.
Some patients notice that the pain eases slightly when lying down, possibly because this position modestly improves blood delivery to the eye. Pain may also result from elevated eye pressure caused by neovascular glaucoma, a complication in which abnormal new blood vessels block the drainage system inside the eye and cause pressure to build dangerously.
Beyond gradual vision changes and eye pain, patients with OIS may notice the following:
- Amaurosis fugax, a temporary blackout of vision in one eye lasting seconds to several minutes, caused by brief interruptions in blood flow
- Prolonged difficulty recovering normal vision after exposure to bright light, because the macula (the central region of the retina responsible for sharp, detailed vision) cannot recover quickly when oxygen delivery is limited
- Slow, progressive dimming or blurring of vision in one eye over time
During a dilated eye exam, in which drops are used to widen the pupil and allow a clear view of the back of the eye, a retina specialist can identify a characteristic pattern of findings. At the front of the eye, abnormal new blood vessels may appear on the iris (the colored part of the eye), a finding present in approximately 60 to 66 percent of OIS cases. Inflammation inside the eye is observed in roughly 20 to 50 percent of patients.
In the back of the eye, the retina shows its own set of characteristic changes. These include narrowed retinal arteries, dilated retinal veins, and small areas of bleeding in the mid-peripheral retina. Microaneurysms (tiny, weak outpouchings in blood vessel walls), cotton-wool spots (white patches where nerve fibers have been damaged by oxygen deprivation), and swelling in the macula may also be present. In advanced or longstanding cases, abnormal new blood vessels may grow on the optic disc or across the retina, leading to additional complications.
How Ocular Ischemic Syndrome Is Diagnosed
Diagnosing OIS requires a structured approach that combines a thorough eye examination, specialized retinal imaging, and evaluation of the carotid arteries. The combination of findings helps distinguish OIS from other retinal conditions that can appear similar.
The diagnostic process begins with a detailed eye examination by a retina specialist. This includes measuring visual acuity (how clearly you can see), checking eye pressure, and examining the retina and optic nerve through dilated pupils. The distinctive pattern of retinal changes in OIS, particularly the combination of arterial narrowing, venous dilation, and mid-peripheral hemorrhages alongside low or normal eye pressure, helps the specialist distinguish it from conditions such as retinal vein occlusion, which can look similar at first glance.
Specialized imaging of the retina plays a critical role in confirming the diagnosis and assessing the extent of damage. Fluorescein angiography involves injecting a harmless dye into a vein in the arm and photographing how it travels through the blood vessels of the retina. In OIS, this test characteristically shows delayed or sluggish filling of the retinal arteries, a pattern that differs clearly from what is seen in a healthy eye or in most other retinal conditions.
Optical coherence tomography (OCT) provides detailed, layer-by-layer images of the retina without the need for dye injection, and it can detect macular edema (fluid buildup and swelling in the center of the retina). OCT angiography, an advanced and entirely non-invasive version of this technology, can visualize retinal blood vessels in three dimensions and reveal reductions in vessel density that are characteristic of OIS. Together, these tools give our team a comprehensive picture of how the eye has been affected.
Because OIS is directly caused by carotid artery disease, imaging of the neck arteries is an essential part of the diagnostic workup. When a retina specialist suspects OIS, the patient will be referred for carotid artery evaluation as part of the assessment. Carotid duplex ultrasound is typically the first test ordered. It uses sound waves to create images of the carotid arteries and measure blood flow velocity, which can reveal the degree of narrowing. CT angiography or MR angiography may follow if more detailed anatomical information is needed to plan treatment.
A diagnosis of OIS always prompts a broader evaluation of cardiovascular health, because the same disease process that affects the carotid arteries typically affects the heart and other blood vessels as well. This assessment includes measurement of blood pressure, blood sugar, and cholesterol, along with evaluation of heart function. Our retina specialists work closely with referring physicians, primary care physicians, and vascular surgery teams to ensure that every patient with OIS receives coordinated care for their systemic health alongside their eye treatment.
Treatment Options for Ocular Ischemic Syndrome
Treating OIS requires addressing both the eye complications and the underlying carotid artery disease. In most cases, several specialists work together to build a care plan tailored to each patient's individual findings and overall health.
The most important step in treating OIS is restoring adequate blood flow through the diseased carotid artery. Two procedures accomplish this: carotid endarterectomy, a surgery in which plaque is physically removed from inside the artery wall, and carotid artery stenting, in which a small mesh tube is placed inside the artery to hold it open. These procedures are performed by vascular surgeons, and our team coordinates referrals promptly when OIS is identified.
Restoring blood flow can prevent further deterioration of the eye and significantly reduce the risk of stroke. In some patients, retinal blood vessel density as measured by OCT angiography has been shown to improve following successful carotid reperfusion. However, the degree of visual recovery depends on how much retinal damage occurred before blood flow was restored, which is one reason early diagnosis matters so much.
Panretinal photocoagulation (PRP) is a laser treatment applied to the outer regions of the retina. It is used when abnormal new blood vessels have developed on the iris, the drainage angle of the eye, or the retina in response to chronic oxygen deprivation. By applying targeted laser energy to the peripheral retina, PRP reduces that tissue's demand for oxygen, which in turn diminishes the chemical signals that drive abnormal vessel growth.
Research indicates that PRP leads to regression (shrinkage and resolution) of abnormal blood vessels on the iris and drainage angle in approximately 35 percent of treated eyes. If neovascular glaucoma has caused the drainage pathway to close, PRP is typically performed before any glaucoma surgery is considered, because reducing the vascular stimulus first can improve surgical outcomes.
Anti-VEGF medications work by blocking vascular endothelial growth factor (VEGF), a protein that stimulates abnormal blood vessel growth and contributes to fluid leakage in the retina. These medications can be injected directly into the vitreous (the gel-filled interior of the eye) to treat complications of OIS, including macular edema and neovascularization. Several anti-VEGF agents are available, and the choice among them is determined by the treating physician based on each patient's specific condition and response to treatment.
Steroid injections into the eye represent another approach to reducing macular edema associated with OIS. This treatment typically requires repeat injections over time and may not be appropriate for all patients. A retina specialist will weigh the potential benefits and risks for each individual and develop an injection schedule when this approach is indicated.
Treating the medical conditions that drive carotid artery narrowing is an essential component of long-term OIS management. Controlling blood pressure, maintaining stable blood sugar in diabetes, lowering cholesterol to recommended levels, and addressing other cardiovascular risk factors all help slow the progression of atherosclerosis throughout the body, including in the arteries that supply the eye. These aspects of care are typically managed by the patient's primary care physician and cardiologist in close communication with our retina team.
What to Expect Over Time
OIS is a serious condition, and realistic expectations are an important part of planning. The outlook for both vision and overall health depends on how quickly the condition is identified and how effectively the underlying vascular disease is treated.
The visual outcome in OIS varies significantly from patient to patient. Even when carotid artery treatment is performed successfully, visual improvement can be limited if the retina has already sustained extensive damage from prolonged oxygen deprivation. Some patients experience stabilization of their vision or modest improvement after carotid surgery and appropriate eye treatment. Others may continue to experience vision decline despite receiving optimal care. Our team will discuss your specific findings openly and help you understand what outcomes are realistic in your situation.
OIS is a marker of serious, widespread cardiovascular disease. Research has shown that the five-year mortality rate among patients with OIS is approximately 40 percent, compared to about 11 percent in people of similar age without the condition. The leading cause of death in this group is heart disease, followed by stroke. These figures underscore the critical importance of aggressive management of all cardiovascular risk factors and the need for ongoing collaboration between the retina team and the broader medical team.
Patients with OIS require regular follow-up with both a retina specialist and their primary care team to monitor for progression and complications. The retina specialist will check for development of neovascular glaucoma, changes in retinal findings, and the eye's response to ongoing treatment. Imaging with OCT and fluorescein angiography may be repeated at each visit to track changes over time. Appointment frequency will be adjusted based on how stable the condition is and whether active treatment is underway.
Living With Ocular Ischemic Syndrome
Long-term management of OIS extends beyond clinic visits. Daily habits, coordination among care teams, and emotional well-being all play a meaningful role in living as well as possible with this condition.
Because OIS is rooted in atherosclerosis, lifestyle changes that protect cardiovascular health also benefit the eyes. A diet low in saturated fats, regular physical activity as recommended by a physician, smoking cessation, and maintaining a healthy weight all help slow the accumulation of plaque in the arteries. While these changes will not reverse existing retinal damage, they can help reduce the risk of further deterioration and lower the overall risk of heart attack and stroke.
Patients with OIS frequently work with several physicians at the same time, including a retina specialist, a vascular surgeon, a cardiologist, and a primary care physician. Keeping all members of the care team informed about new symptoms, medication changes, and test results is essential for safe and effective treatment. Bringing a current and complete medication list to every appointment, including those with specialists outside the eye care team, is a practical habit that helps prevent important information from being overlooked.
Learning that you have OIS can understandably cause concern, both because of what it means for your vision and because of what it reveals about your overall vascular health. Patients who have experienced meaningful vision loss may benefit from low-vision rehabilitation services, which are designed to help people make the most of remaining vision through specialized training and assistive devices. Support from family, friends, and community resources can ease the burden of daily tasks that become more difficult. We encourage patients to speak openly with our team about their concerns, expectations, and quality of life at every visit.
When to Seek Urgent Eye Care
Certain eye symptoms cannot wait for a scheduled appointment and require immediate evaluation. Recognizing these warning signs could make a critical difference in preserving vision and overall health.
Contact a retina specialist or go to an emergency room right away if you experience any of the following:
- Sudden loss of vision in one eye, even if it seems to recover on its own
- A dark shadow, curtain, or area of missing vision moving across your visual field
- A sudden and significant increase in floaters (spots, threads, or webs drifting through your vision)
- Repeated flashes of light in one eye, especially if they are new or increasing in frequency
- A temporary complete blackout of vision in one eye lasting seconds to several minutes
Even without sudden changes, you should schedule an evaluation with a retina specialist if you have been experiencing gradual or slowly worsening vision in one eye, particularly if you have known carotid artery disease, high blood pressure, diabetes, high cholesterol, or a history of stroke or heart attack. A persistent dull ache around one eye that tends to ease when you lie down is another reason to seek prompt evaluation. The earlier OIS is identified, the greater the opportunity to protect vision and address the underlying vascular disease before it causes further harm to the eye or the rest of the body.
Frequently Asked Questions
Below are answers to questions that patients and referring physicians commonly raise about ocular ischemic syndrome.
OIS most commonly affects one eye, but both eyes can be involved when significant atherosclerosis affects both carotid arteries. When both eyes are affected, the findings and symptoms are typically more severe on the side with greater narrowing. During evaluation, a retina specialist will examine both eyes thoroughly and may recommend imaging of both carotid arteries to understand the full extent of vascular disease. Management decisions will account for each eye's findings individually, and treatment may be prioritized based on severity.
Because OIS results from the same atherosclerosis that causes heart attacks and strokes, reducing cardiovascular risk factors is the most practical preventive strategy. Controlling blood pressure, managing blood sugar in diabetes, maintaining healthy cholesterol levels, not smoking, and staying physically active all reduce plaque buildup in the arteries over time. Regular medical checkups that include cardiovascular risk assessment are particularly valuable for adults over age 50, especially those with a personal or family history of heart or vascular disease. These habits will not guarantee prevention, but they meaningfully lower the risk.
When OIS is identified in the eye, it confirms that the carotid artery supplying that eye is severely diseased. Because the same arteries supply blood to the brain, the risk of stroke is elevated. Addressing only the eye complications while leaving the carotid artery disease untreated would leave the most life-threatening aspect of the condition unmanaged. Immediate coordination with a vascular surgeon and cardiologist is not optional for patients with OIS. It is a necessary part of every treatment plan, and our team initiates those referrals promptly.
Both conditions can produce retinal hemorrhages, dilated veins, and vision changes, which is why they are sometimes confused on initial evaluation. The key distinction lies in the direction of blood flow disruption. A retinal vein occlusion blocks blood from flowing out of the eye through the veins, creating a backup of pressure and fluid. OIS reduces blood flowing into the eye through the carotid and ophthalmic arteries, creating a state of deprivation. On fluorescein angiography, OIS typically produces delayed arterial filling, a pattern not seen in vein occlusion. Eye pressure also differs: OIS is often associated with low or normal eye pressure, while vein occlusions more commonly cause elevated pressure. These distinctions guide the retina specialist toward the correct diagnosis and the appropriate treatment approach.
Not every patient with OIS requires intravitreal injections. Injections are reserved for patients who develop specific complications such as macular edema or abnormal blood vessel growth that does not respond adequately to laser treatment. The primary and most important treatment remains restoring blood flow through the carotid artery. A retina specialist will evaluate each patient individually and recommend injections only when they are appropriate for the specific findings present. Some patients are managed with carotid intervention and careful monitoring alone, while others require a combination of surgery, laser, and injections.
Follow-up frequency depends on the severity of OIS and whether active treatment is underway. Patients who are newly diagnosed or receiving treatment for complications may be seen monthly or more frequently until the condition stabilizes. As findings improve or plateau, appointment intervals may be extended. Because OIS can evolve between visits, especially during the early phase of management, it is important to keep all scheduled appointments and to contact our office promptly if new symptoms develop. Your retina specialist will set a schedule based on your individual situation and adjust it as your condition evolves over time.
Schedule Your Evaluation at New England Retina Associates
If you have been referred for evaluation of ocular ischemic syndrome, or if you have symptoms or risk factors that concern you, we welcome you to reach out to New England Retina Associates. Our fellowship-trained vitreoretinal surgeons serve patients throughout Connecticut and bring deep expertise in diagnosing and managing complex retinal vascular conditions. We work closely with your referring physician and the rest of your care team to ensure that every aspect of your health, from your eyes to your overall vascular wellbeing, receives the coordinated, expert attention it deserves.
30 Years of Care & Commitment
